SYNTHETIC RECORD, NOT A REAL MEDICAL RECORD — Progress Note 4 — Sick Visit — David Hume

PatientDavid Hume
Date of birth1962-05-07
IdentifiersMRN HR-EN012-SYN; SSN (made up) 000-12-3049
Document date2026-09-08
AuthorFiona Gallacher, MD
CustodianSt. Posthumous Health Center

Readable copy of the C-CDA narrative, generated with the XML. Coded entries are in the XML file beside this page.

Chief Complaint

Runny nose, sore throat, and cough for three days during chemotherapy. [S]

History of Present Illness

Mr. Hume is a 64-year-old man with stage IIIB sigmoid colon cancer, resected in June, who is on day 9 of his third 21-day cycle of adjuvant CAPOX (oxaliplatin given on day 1, capecitabine on days 1 to 14). Three days ago he developed a runny nose and scratchy throat, followed by a dry cough. He called the oncology triage line this morning, as his chemotherapy plan instructs, and was asked to be seen in primary care today with a blood count. His home temperatures have been 37.1 to 37.4 °C, checked twice daily, and he has not taken acetaminophen, so no fever has been masked. A home COVID-19 antigen test yesterday was negative. He is eating and drinking normally, has had two soft stools a day without diarrhea, no mouth sores, and no redness or peeling of his palms or soles. The cold tingling in his fingers after each oxaliplatin dose settles within five days, as before. A friend who visited last week had a cold. [S]

ElementDetail
OnsetThree days ago
LocationNose, throat, and chest
DurationThree days
CharacterClear nasal discharge, scratchy throat, dry cough
SeverityMild; sleeping normally
TimingDay 9 of the third CAPOX cycle
ContextExposure to a visitor with a cold; on capecitabine
Modifying factorsWarm drinks help; no medicines taken
Associated signs and symptomsNo fever, chills, breathlessness, chest pain, diarrhea, mouth sores, or hand-foot symptoms

Review of Systems

SystemResultFinding
ConstitutionalNegativeNo fever above 37.4 °C, chills, or rigors; usual chemotherapy tiredness
Ears, nose, mouth, and throatPositiveClear rhinorrhea and sore throat; no mouth ulcers, ear pain, or facial pain
RespiratoryPositiveDry cough; no breathlessness, wheeze, sputum, or hemoptysis
CardiovascularNegativeNo chest pain or palpitations
GastrointestinalNegativeNo nausea, vomiting, diarrhea, or abdominal pain
GenitourinaryNegativeNo dysuria or frequency
IntegumentaryNegativeNo palmar or plantar redness, peeling, or blistering
NeurologicalPositiveBrief cold-triggered tingling of the fingers after oxaliplatin, resolving between doses; no numbness at rest

8 systems reviewed. [S]

Medications

MedicationFrequencyRouteDatesStatusEvidence
Ferric carboxymaltose 750 mg intravenous infusion, two doses one week apart750 mg IV once a week for two dosesIntravenous route2026-06-01 to 2026-06-08completedS
Capecitabine 500 mg oral tablet, four tablets (2000 mg, 1000 mg/m²) by mouth twice daily on days 1 to 14 of each 21-day cycle, four cyclesFour tablets twice daily on days 1 to 14 of each 21-day cycleOral route2026-07-20 to 2026-10-04completedS
Oxaliplatin 130 mg/m² (260 mg) intravenous infusion on day 1 of each 21-day cycle, four cycles260 mg IV on day 1 every 21 daysIntravenous route2026-07-20 to 2026-09-21completedS
Ondansetron 8 mg oral tablet, one tablet by mouth every 8 hours as needed for nausea during chemotherapyOne tablet every 8 hours as needed for nauseaOral route2026-07-20 to 2026-10-04completedS
Loperamide 2 mg oral capsule, two capsules after the first loose stool, then one after each loose stool, no more than eight a dayAs needed for diarrhea on capecitabineOral route2026-07-20 to 2026-10-04completedS

Allergies and Intolerances

AllergyReactionStatusEvidence
No known allergyactiveS

Vital Signs

DateMeasureValueUnitProvenance
2026-09-08Body height178cmS
2026-09-08Body weight81.6kgS
2026-09-08Body mass index (BMI) [Ratio]25.8kg/m2S
2026-09-08Systolic blood pressure118mm[Hg]S
2026-09-08Diastolic blood pressure72mm[Hg]S
2026-09-08Heart rate84/minS
2026-09-08Respiratory rate16/minS
2026-09-08Body temperature37.3CelS
2026-09-08Oxygen saturation in Arterial blood by Pulse oximetry97%S

Results

DateMeasureValueUnitReference rangeFlagProvenance
2026-09-08Leukocytes [#/volume] in Blood by Automated count4.610*3/uL4-11 10*3/uLNormalS
2026-09-08Neutrophils [#/volume] in Blood by Automated count2.410*3/uL1.5-7.7 10*3/uLNormalS
2026-09-08Hemoglobin [Mass/volume] in Blood12.1g/dL13.2-16.6 g/dLLowS
2026-09-08Platelets [#/volume] in Blood by Automated count15610*3/uL150-400 10*3/uLNormalS

Physical Exam

Vital signs recorded on 2026-09-08; see the Vital Signs section. [S]

SystemFinding
GeneralWell-appearing, comfortable, speaking easily
Ears, nose, and throatNasal mucosa red with clear discharge; pharynx mildly red without exudate; no oral mucositis
NeckNo tender or enlarged nodes
RespiratoryUnlabored; clear to auscultation; no crackles or wheeze
CardiovascularRegular rhythm, heart rate 84
AbdomenLaparoscopic port scars healed; soft and non-tender
SkinPalms and soles normal

Problems

ProblemClinical statusVerificationCodeProvenance
Adenocarcinoma of the sigmoid colon, suspected at presentation and confirmed by colonoscopic biopsy; synthetic modern diagnosis linked to the documented 1775 bowel disorder and its retrospective interpretation as colon canceractiveconfirmed C18.7S — Synthetic diagnosis confirmed by biopsy and resection in the modern episode; the historical diagnosis remains a retrospective interpretation (R).
Iron deficiency anemia from chronic blood loss from the colon tumoractiveconfirmed D50.0S — Synthetic finding echoing the documented 'hemorrhage in the upper part of the intestines'; no blood count from his lifetime exists.
Hemangioma of the liver, 9 mm, segment VI; incidental finding characterized by MRI, not a metastasisactiveconfirmed D18.03S — Synthetic incidental finding; it addresses, and does not confirm, the unverified suggestion of liver spread.
Acute viral upper respiratory infection during adjuvant chemotherapy, without fever or neutropenia; resolvedresolvedconfirmed J06.9S — Synthetic intercurrent illness at an unscheduled visit; it does not echo a documented illness.

Assessment and Plan

Guideline basis: NCCN Clinical Practice Guidelines in Oncology: Colon Cancer, Version 4.2025 (2025); Outpatient Management of Fever and Neutropenia in Adults Treated for Malignancy: American Society of Clinical Oncology and Infectious Diseases Society of America Clinical Practice Guideline Update (2018); Appropriate Antibiotic Use for Acute Respiratory Tract Infection in Adults: Advice for High-Value Care From the American College of Physicians and the Centers for Disease Control and Prevention (2016)

Follow-up: Oncology team updated today. Nurse telephone check in two days. Cycle 4 as scheduled if well. Next scheduled visit 2026-10-19: review two weeks after completing adjuvant CAPOX and start of survivorship surveillance. [S]